AmpC β-lactamases in Southeast Asian E. coli and K. pneumoniae
Author Information
Author(s): Tamalee Roberts, Clare L. Ling, Wanitda Watthanaworawit, Chanvoleak Cheav, Amphonesavanh Sengduangphachanh, Joy Silisouk, Jill Hopkins, Koukeo Phommasone, Elizabeth M. Batty, Paul Turner, Elizabeth A. Ashley
Primary Institution: Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford
Hypothesis
What is the prevalence of AmpC β-lactamase-producing E. coli and Klebsiella pneumoniae in Southeast Asia?
Conclusion
AmpC and inducible AmpC β-lactamases are important causes of infection in Southeast Asia, often going undetected with current testing methods.
Supporting Evidence
- 31 out of 126 isolates were phenotypically AmpC positive.
- All inducible AmpC isolates were ceftriaxone susceptible.
- 97.7% of AmpC/inducible AmpC isolates tested against cefoxitin were resistant.
- 12 different β-lactamase resistance genes were detected.
- Cefoxitin screening is part of EUCAST guidelines.
Takeaway
Some germs in Southeast Asia can resist important medicines, making it hard to treat infections. We need better tests to find these germs.
Methodology
The study screened clinical isolates for AmpC β-lactamase production using MASTDISCS and whole-genome sequencing.
Potential Biases
Quality control was not thorough due to the absence of appropriate control strains at all sites.
Limitations
Different testing methods were used across sites, and not all isolates were sequenced due to financial constraints.
Participant Demographics
Isolates were collected from three clinical research sites in Cambodia, Laos, and Thailand.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website